A PhD position is available in the Laboratory of Cancer Epigenetics headed by Prof. François Fuks at the Université libre de Bruxelles (ULB), Brussels, Belgium.

You will be expected to conduct cancer research in epigenetics and epigenomics. Specifically, you will investigate the mechanisms and functions of a novel epigenetic modification. The following recent publication has direct relevance to this project: Delatte B, et al., Science. 2016; 351:282-5. Genetic, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq, ChIP-Seq, Infinium Methylation) will be applied. The lab is running a Next Generation Sequencing (NGS) Illumina platform: EPICS, and is part of the new ULB-Cancer Research Center (U-CRC) directed by Prof. Fuks, providing an excellent scientific environment to conduct high profile research encompassing fundamental, translational and clinical research.

Candidates with a good first degree (BSc or MSc) in Biology, Genetics, Biochemistry or a related life science subject are all invited to apply. Preferred qualifications include excellent grades, research talent (as proven by the master thesis) and personal ambition. Candidates are expected to have good academic writing and presentation skills. Screening of applications begins immediately and continues until an outstanding candidate is selected.

The position is funded for 3 years, in the first instance. Screening of applications begins immediately and continues until an outstanding candidate is selected. The starting date is September 30, 2016 at the latest.

Informal enquiries, a CV (including grades and class ranking), a motivation letter and names of three referees should be send to: Valentina Albarani (valentina.albarani@ulb.ac.be)

Lab website: http://www.ulb.ac.be/medecine/fukslab

Lab NGS platform EPICS: http://epics.ulb.be/

University website: https://www.ulb.ac.be/ulb/presentation/uk.html

Selected publications:
– Delatte et al. Science 2016
– Boumahdi et al. Nature 2014
– Deplus et al. Cell Rep. 2014
– Delatte et al. EMBO J. 2014
– Deplus et al. EMBO J. 2013
– Volkmar et al. EMBO J. 2012
– Dedeurwaerder et al. EMBO Mol Med. 2011
– Fuks F. Nature 2010
– Villa et al. Cancer Cell 2007
– Viré et al. Nature 2006